Travel looks different these days, but it can be done safely. Face coverings are required, you may know more about cleaning protocols than before, plus proof of a negative COVID-19 test is necessary for travel to several destinations. But, with so many testing options out there, how do you choose?
The airline industry is complex, and American Minute makes it simpler to understand.
United CleanPlus℠ is our commitment to delivering industry-leading cleanliness as we put health and safety at the forefront of your experience. We’ve teamed up with Clorox to redefine our cleaning and disinfection procedures and Cleveland Clinic to advise us on enhancing our cleaning and disinfection protocols – all to help support a healthier and safer environment throughout your travel journey.
We’re dedicated to bringing the United CleanPlus commitment to you in three distinct ways:
Innovation is vital for a business to establish a competitive advantage. Putting it to work is another challenge in itself, however, and success often comes only after a protracted period of trial and error.
Take CLP’s digital solutions platformSmart Energy Connect (SEC) as an example. Its ability to rebound from the setbacks it encountered in offering an indoor air quality solution provides a useful lesson in the value of persistence.
You'll now be able to upload and validate COVID-19 test results, review local entry requirements, find testing providers and store vaccination records all in the "My Trips" section of the United app or website.
Top industry leaders and venture firms unite behind Ukko’s efforts to eliminate the world's most prevalent food allergies and sensitivities, including peanuts and gluten
Palo Alto /Tel Aviv / Leverkusen, January 27, 2021 /3BL Media/ – Ukko, a biotech company with the mission to eliminate food allergies and sensitivities, today announced USD 40 million in new Series B funding. Ukko harnesses artificial intelligence (AI) and protein engineering to develop healthier food and therapies for food allergies. The new funding will allow Ukko to enter clinical trials with its investigational therapeutic for peanut allergies. It will also accelerate development of Ukko’s gluten that is designed for people with celiac and other gluten sensitivities.
Holistic suite of solutions to include rapid deployment vaccine facilities and digital data management
OVERLAND PARK, Kansas, January 25, 2021 /3BL Media/ – Oncor Consulting – a consultancy owned and led by physicians – is expanding its alliance with Black & Veatch to add additional capabilities to its Passport digital health management solution, helping organizations seeking a holistic approach to coordinating COVID-19 vaccine distribution and administration.